| abstract |
Disclosed are several novel genes, identified in screening assays based upon binding to the breast cancer protein, BRCA1. The currently preferred gene and protein, termed BARD1, is a RING protein that interacts with BRCA1. The genes, proteins and other biological materials provided are envisioned for use in various cancer-related diagnostic and therapeutic methods, particularly those connected with breast, ovarian and uterine cancer. |